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Abstract
AMP-activated protein kinase (AMPK), a phylogenetically conserved serine/threonine protein kinase, is proposed to function
as a ‘‘fuel gauge’’ to monitor cellular energy status in response to nutritional environmental variations. However, in fish, few
studies have addressed the metabolic consequences related to the activation of this kinase. This study demonstrates that
the rainbow trout (Oncorhynchus mykiss) possesses paralogs of the three known AMPK subunits that co-diversified, that the
AMPK protein is present in the liver and in isolated hepatocytes, and it does change in response to physiological (fasting-re-
feeding cycle) and pharmacological (AICAR and metformin administration and incubations) manipulations. Moreover, the
phosphorylation of AMPK results in the phosphorylation of acetyl-CoA carboxylase, a main downstream target of AMPK in
mammals. Other findings include changes in hepatic glycogen levels and several molecular actors involved in hepatic
glucose and lipid metabolism, including mRNA transcript levels for glucokinase, glucose-6-phosphatase and fatty acid
synthase both in vivo and in vitro. The fact that most results presented in this study are consistent with the recognized role
of AMPK as a master regulator of energy homeostasis in living organisms supports the idea that these functions are
conserved in this piscine model.
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Introduction
Intracellular ATP concentrations must be maintained within a
narrow range to sustain appropriate metabolic function. Recent
evidence indicates that the coordination of this task is achieved
through the AMP-activated protein kinase (AMPK) [1]. This
kinase is typically activated by an increase in the AMP:ATP ratio.
In its active form, the AMPK regulates a large number of
downstream targets that together lead to a reduction in anabolic
pathways and a stimulation of catabolic pathways. The net result
of AMPK activation is the stabilization of ATP levels and
restoration of energy balance [2].
The AMPK of mammals exists as a heterotrimeric complex
consisting of a catalytic a subunit and two regulatory subunits b
and c [1]. The conventional serine/threonine kinase activity of
AMPK is supported by the a subunit, which is characterized by
t h ep r e s e n c eo fat h r e o n i n er e s i d u e( T h r
172) activation loop
whose phosphorylation is required for full activation. Homo-
logues of all three subunits exist in mammals, invertebrates,
yeast, plants and the primitive protozoa, with a high degree of
conservation suggesting that this signaling pathway evolved
over one billion years ago to regulate metabolic homeostasis,
although the exact evolutionary dynamics of AMPK are unclear
[3].
The existence of AMPK is reported in several fish species
including goldfish (Carassius auratus) [4], zebrafish (Danio rerio) [5],
crucian carp (Carassius carassius) [6] and salmon (Salmo salar) (Markus
Frederich and Jennifer Jost, unpublished observations). Addition-
ally, numerous submissions to gene databases complete the list of
species in which this kinase is reported including puffer fish
(Tetraodon nigroviridis, Takifugu rubripes), stickleback (Gasterosteus
aculeatus), and the Japanese ricefish (Oryzias latipes). Despite this
apparent wide distribution in the piscine model, only a few studies
have dealt with AMPK functions in fish or have established a
phylogenetic relationship of AMPK subunits as found in fish and
other vertebrates. Three different studies published nearly simulta-
neouslyaddressedtherole ofAMPKinhypoxia-relatedfunctionsall
in hypoxic-insensitive cyprinids [4,5,6]. However, the only
information regarding the metabolic consequences of the activation
of this kinase in fish reported an increased metabolic rate in anoxic
crucian carp treated with the AMPK inhibitor Compound C [6];
thus, further studies on AMPK function are warranted.
Mammalian AMPK is inactive unless phosphorylated by
upstream kinases, with the critical phosphorylation site being
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172 within the ‘‘activation loop’’ of the kinase domain within
the a subunit [7]. Either 59-AMP or the AICAR phosphorylated
form (5-amino-4-imidazolecarboxamide ribotide [8]) activates
AMPK by binding to the c subunit [7]. This binding (i) promotes
phosphorylation by the upstream kinase, (ii) allosterically activates
the phosphorylated kinase, and (iii) inhibits dephosphorylation of
Thr
172 by protein phosphatases. There are at least two signaling
pathways upstream of AMPK: one is triggered by an increase in
the AMP:ATP ratio and dependent on LKB1, and the other is
triggered by an increase in Ca
2+ and is dependent on CaMKKb
[7]. Winder and Hardie [9] proposed that activators of AMPK
may be effective treatments for type 2 diabetes. Later studies
supported this idea, since AMPK was a potential target for
biguanide antidiabetic drugs like metformin and phenformin,
being activated in intact cells and/or in vivo through a LKB1-
dependent mechanism [10,11]. In fish, metformin is able to
improve glucose homeostasis when administrated intraperitoneally
(IP) [12], infused using osmotic pumps [13] or included in the food
[14]. However, to date, the involvement of AMPK in this action
remains to be elucidated.
The present study places the rainbow trout AMPK subunits into
a phylogenetic context and shows that all three subunits diversified
at approximately the same geological time. We employ two known
activators of AMPK, AICAR and metformin (1,1-dimethylbigua-
nide hydrochloride) to explore the metabolic effects of the
activation of AMPK in rainbow trout liver. Using mammalian
antibodies, we identified in both trout liver and isolated
hepatocytes the phosphorylation status of AMPK and indirectly
assessed its activity by examining the phosphorylation of the
AMPK downstream target acetyl-CoA carboxylase (ACC) at the
serine residue (Ser
79). We also conducted complementary
experiments to establish whether physiological conditions modify
trout liver AMPK, including feeding trout with metformin-
supplemented diets or subjecting trout to a fasting-re-feeding
cycle. Furthermore, we assessed hepatic glycogen levels and, at the
molecular level, the activity of several representative genes of
glucose and lipid metabolism in liver and isolated hepatocytes to
explore the potential metabolic effects of AMPK activation.
Materials and Methods
Fish
Rainbow trout (Oncorhynchus mykiss Walbaum) were obtained
from the INRA experimental fish farm facilities of Donzacq
(Landes, France). Fish were maintained in tanks kept in open
circuits supplied with 17uC well aerated water under a controlled
photoperiod (LD 12:12) and fed with a commercial diet (T-3P
classic, Trouw, France). Fish weighed 3362 g for the AICAR
experiments and 8464 g for the metformin experiments. The
experiments were conducted following the Guidelines of the
National Legislation on Animal Care of the French Ministry of
Research (Decree 2001-464 of May 29, 2001) and were approved
by the Ethics Committee of INRA (according to INRA 2002-36 of
April 14, 2002).
Phylogenetic analysis
Sequences were downloaded from GenBank at the National
Center for Biotechnology Information (www.ncbi.nlm.nih.gov).
The human sequence of each paralog of each subunit was used as
a BLASTn query to find all other sequences used in this study. A
number of sequences from the chordates were retrieved, including
a relatively large number of mammal sequences (i) to be able to use
some of the fossil divergences as calibration priors (see below) and
(ii) in order to check that accurate species trees were obtained for
each paralog. Only sequences with an E-value ,10
2500 were used.
The rainbow trout sequences were accessed by routine 5’RACE
PCR and PCR experiments using human AMPK isoform primers.
The resulting trout sequences were uploaded to GenBank
(accession numbers: HQ403672-HQ403678).
The protein-coding parts of these sequences were extracted, and
aligned with Muscle [15] for each subunit. The alignments were
edited with Jalview [16]. The identity of the paralogs was
checked with a preliminary phylogenetic analysis where each tree
(for a, b and c) was reconstructed under maximum likelihood
using GTR + C4 (four discrete rate categories) and NNI + SPR in
PhyML ver. 3.0 [17]. One thousand bootstrap replicates were
generated to check the support for each internal bipartition. For all
subsequent analyses, the best substitution model to be used for the
analysis of each subunit was selected based on the Akaike
Information Criterion as implemented in ModelTest [18].
The dated phylogenetic analysis relied on a relaxed molecular
clock model as implemented in BEAST [19]. Fossil information
was extracted from [20] with the selection of five divergences:
Amniota/Amphibia (Homo/Xenopus: 0.330 billion years ago; BYA),
Mammalia/Sauropsida (Homo/Gallus: 0.306 BYA), Hominoidea/Cerco-
pithecoidea (Homo/Macaca: 0.020 BYA), Theria/Prototheria (Homo/
Ornithorhynchus: 0.200 BYA) and Actinopterygii/Sarcopterygii (Danio/
Gallus: 0.450 BYA). These fossil dates were used as minimum ages
in the model, and mean 0.05 exponential prior distributions were
used (note that times are in units of billion years). A vague
lognormal prior (mean 0.5 and standard deviation 0.5) was placed
on the root of each tree, with a minimum age of 0.450 BYA. The
prior on rates was lognormal, and that on times was a pure-birth
(Yule) process. The Markov chain Monte Carlo (MCMC)
samplers were run in duplicates (to check convergence) for 100
million generations with a thinning of 2000 (see [21] for a brief
introduction). Convergence was checked with Tracer (tree.-
bio.ed.ac.uk), which was also used to determine burn-in periods.
After excluding the burn-in periods, each of the two replicate runs
were combined and summarized with TreeAnnotator [19].
Note that no outgroup is required to root the tree when estimating
divergence times (e.g., [22]).
In vivo experimental protocols
For drug administration, 48 h-fasted fish were lightly anesthe-
tized (0.05% (v/v) 2-phenoxyethanol), weighed, and intraperito-
neally (ip) injected with 5 ml?kg
21 body mass saline solution alone
(control, n=6) or saline containing either AICAR (1.4 g?kg
21;
Cayman) or metformin (120 mg?kg
21; Sigma). Sampling was
initiated 2 h after the injection when six fish per group were
randomly sampled and their liver immediately frozen in liquid
nitrogen and kept at 280uC pending analyses.
The fasting-re-feeding trial was done with rainbow trout (fish
mass 9563 g) fasted for 10 days and then re-fed with a semi-
purified diet (30% dextrin, 57% fish meal and 10% fish oil). Liver
samples were taken before the re-feeding at 1 and 24 h after the
meal. The nutritional study followed the experimental design
described in Panserat et al. [14]. Briefly, two high carbohydrate
and isocaloric diets were formulated and manufactured in the
INRA facilities (30% gelatinized starch, 57% fish meal and 10%
fish oil). One diet was supplemented with metformin (Merck, Paris,
France) at a level of 0.25% while the other contained no
metformin. Fish were hand-fed twice daily at 2% body weight
for 10 days with the high-carbohydrate diet alone. After this
period, fish were fed an additional 3 days with either the
carbohydrate diet alone or the carbohydrate + metformin diet. At
the end of the trial, six fish per group were sampled 2 h after the
meal to follow the postprandial phase. All fish were killed by a
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frozen in liquid nitrogen and kept at 280uC until analyzed.
In vitro experimental protocols
Isolated liver cells were prepared from four day-fasted rainbow
trout as previously described by Mommsen and colleagues [23]
with the modifications mentioned in Plagnes-Juan et al. [24].
Briefly, after anaesthesia, livers were perfused and digested in situ,
excised and minced with a razor blade. After filtration and
centrifugation (120 g, 2 min), the resulting cell pellets were
resuspended three successive times in a modified Hanks’ medium
(136.9 mM NaCl, 5.4 mM KCl, 0.81 mM MgSO4, 0.44 mM
KH2PO4, 0.33 mM Na2HPO4, 5 mM NaHCO3 and 10 mM
Hepes, pH=7.63) and centrifuged (70 g, 2 min). Cells were finally
suspended in the modified Hanks’ medium supplemented with
1.5 mM CaCl2, 1% defatted BSA, 4?10
29 M bovine insulin
(Sigma), 20 mM glucose, MEM essential amino acids (1x;
Invitrogen), MEM non-essential amino acids (1x; Invitrogen) and
antibiotic antimycotic solution (1x; Sigma). Hepatocytes were
plated in six well culture dishes at a density of 3?10
6 cells per well
and incubated at 18uC. The incubation medium was replaced
every 24 h over the 72 h primary cell culture period. For protein
analysis, 48 h-cultured hepatocytes were stimulated using either
metformin or AICAR at 0.5 mM for 16 h, doses used previously
for mammalian cell culture studies [25,26]. At the end of the
stimulation period, cells were collected for protein extraction.
Western blot and qPCR analysis
Protein extraction (20 mg) and Western blotting were undertak-
en as in [13] using anti-phospho-AMPKa Thr
172 and anti-AMPK
antibodies (Cell Signaling Technology, France) that recognize
both a-1 and a-2 isoforms of the enzyme. For ACC, Akt and b-
tubulin blots, anti-phosphor-ACC Ser
79 and anti-b-tubulin
antibodies (Cell Signaling Technology, France) were used as
noted previously. Frozen livers or hepatocytes were homogenized
on ice with an Ultraturrax homogenizer in a buffer containing
150 mM NaCl, 10 mM Tris, 1 mM EGTA, 1 mM EDTA
(pH=7.4), 100 mM sodium fluoride, 4 mM sodium pyrophos-
phate, 2 mM sodium orthovanadate, 1% Triton X-100, 0.5% NP-
40-IGEPAL and a protease inhibitor cocktail (Roche, Basel,
Switzerland). Homogenates were centrifuged for 15 min at
12,000 g and the resulting supernatants stored at 280uC. Protein
concentrations were determined using the Bio-Rad protein assay
kit (BIO-RAD, Hercules, CA, USA). Protein lysates (20 mgo f
protein) were subjected to SDS-PAGE and Western blotting using
the appropriate antibody. After washing, membranes were
incubated with an IRDye infrared secondary antibody (LI-COR
Inc. Biotechnology, Lincoln, NE, USA). Bands were visualized by
Infrared Fluorescence using the OdysseyH Imaging System (LI-
COR Inc. Biotechnology, Lincoln, NE, USA) and quantified by
Odyssey infrared imaging system software (Application software,
version 1.2).
Liver mRNA levels for GK (glucokinase), G6Pase (glucose 6-
phosphatase), FAS (fatty acid synthase), PEPCK (phosphoenol-
pyruvate carboxykinase) and FBPase (fructose 1,6-bisphosphatase)
were estimated by real-time quantitative RT-PCR (q-PCR) [13].
Primers were designed to overlap an intron where possible
(Primer3 software) using known sequences found in trout
nucleotide databases (GenBank and INRA-Sigenae) and AMPK
partial sequences (see Table 1) as previously described [13].
Quantification of the target gene transcript level was done using
ef1a gene expression as reference, which was found to be stably
expressed in this study. Relative quantification of the target gene
transcript with the ef1a reference gene transcript was made
following the Pfaffl method [27].
Due to the similarities of the AMPKa1 and AMPKa2 isoforms,
probe-based qPCR was employed to detect differences in
expression from liver samples. Briefly, first strand cDNA was
synthesized using QuantiTect Reverse Transcription Kit (Qiagen).
mRNA expression was quantified in duplicate on a Stratagene
MX3000P real-time PCR machine using probe based (FAM
labeled) PrimeTime Mini qPCR Assays (Integrated DNA
Technologies). Each reaction contained 12.5 ml SYBR green
mix, 1 ml primer/probe mix, 0.375 ml ROX reference dye (1:500
dilution), 10.125 ml RNase/DNase-free H2O, and 1 mlo f5 x
diluted cDNA template. Cycling conditions were as follows:
10 min initial denaturation at 95uC, 40 cycles at 95uC for 30 s,
and 60uC for 1 min. To account for differences in amplification
efficiency between different cDNAs, standard curves were
constructed for each target gene using serial dilutions of quantified
liver and muscle cDNA. To account for differences in cDNA
production and loading differences, all samples were normalized to
the expression level of the housekeeping gene b-actin, which did
not change over the course of the experimental treatments. Gene
expression data were calculated using the 2
DD- method of Pfaffl
[27]. Both RNase/DNase-free H2O and non-reverse transcribed
RNA were assayed on each plate to ensure the absence of
contamination in the reagents and primers used. Primers were
designed using Integrated DNA Technologies online assay design
program and can be found in Table 1.
Statistical analysis
Results are expressed as means 6 s.e.m. (n=6) and were
analyzed by one-way ANOVA to compare groups receiving drug
Table 1. Sequences of the primer pairs used for real-time
quantitative PCR determination of the transcript levels of
several rainbow trout genes involved in glucose, lipid and
energy metabolism.
Gene 59-39 forward primer 59-39 reverse primer
SybrGreen
GK TGAAGGATCAGAGGTGGGTGAT GAAGGTGAAACCCAGAGGAAGC
G6Pase CTCAGTGGCGACAGAAAGG TACACAGCAGCATCCAGAGC
FBPase GCTGGACCCTTCCATCGG CGACATAACGCCCACCATAGG
PEPCK GTTGGTGCTAAAGGGCACAC CCCGTCTTCTGATAAGTCCAA
FAS GAGACCTAGTGGAGGCTGTC TCTTGTTGATGGTGAGCTGT
EF1 a TCCTCTTGGTCGTTTCGCTG ACCCGAGGGACATCCTGTG
TaqMan
AMPK a 1 CACCATCAAAGAGATCCGAGAG TCAAACTTCTCACACACCTCC
Probe:/56-FAM/ATGAGCTCC/ZEN/CCAAGTACCTGTTTCC/
3IABKFQ/
AMPK a 2 GGGCTACCATTAAAGACATTAGGGACTCGGTGCTCTCAAACTTG
Probe:/56-FAM/TCGGACTGC/ZEN/CTCCTCATCCAGA/3IABKFQ/
b-actin CAATGAGACTGAGAAGCTGGG GACTGTACCCATCCCAAACG
PROBE: FAMCCACACCCGACTACCACTTCAGC/3IABKFQ
GenBank accession no. or sigenae accession no.: EF1a (elongation factor 1a),
AF498320; GK (glucokinase), AF135403; PEPCK (phosphoenolpyruvate
carboxykinase), AF246149; G6Pase (glucose 6-phosphatase),
tcay0019b.d.18_3.1.s.om.8.1-1693; FBPase (fructose 1,6-bisphosphatase),
AF333188; FAS (fatty acid synthase), tcab0001c.e.06_5.1.s.om.8; AMPK a 1,
HQ403672; AMPK a 2, HQ403673.
doi:10.1371/journal.pone.0020228.t001
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posteriori multiple comparison test. The level of significance was set
at a,0.05.
Results
Phylogeny of AMPK subunits
Rainbow trout AMPK genes were sequenced for the a subunit
(a1: HQ403672, a2: HQ403673), b subunit (b1.1: HQ403674;
b2: HQ403675) and c subunit (c1: HQ403676, c2.1: HQ403677,
c2.2: HQ403678). The dot notation for the fish-specific paralogs is
ours. No c3 sequences were obtained. The actual identification of
these sequences was performed through a phylogenetic analysis,
conducted as described in the Materials and Methods. The
BLASTn searches (conducted in November 2010) for AMPK
subunits returned 52 a sequences, 52 b sequences and 76 c
sequences. The only c3 sequence found in fish was that of
Gasterosteus aculeatus; no other fish c3 sequences were found, even
with a more sensitive tBLASTx search. The preliminary
phylogenetic analysis led us to eliminate isoforms due to transcript
variants, duplicates and sequences of poor quality, resulting in
three final data sets comprising 47 a sequences, 47 b sequences
and 73 c sequences.
The relaxed clock analysis (Fig. 1) reconstructed a rooted tree
that clearly shows the whole-genome duplication (WGD) events
from which emerged the paralogs of the three subunits. Quite
strikingly, most paralogs emerged at the occasion of the same
WGD event, here dated between ,0.775 and 0.450 BYA (Mid-
Cryogenina to Upper Ordovician), which corresponds to the
second round of WGD that took place in the vertebrates. Subunit-
specific singularities exist though. The a subunit, which is the only
one for which we found non-vertebrate chordates in GenBank,
shows that the duplication giving rise to the a1 and a2 subunits
took place after the Chordata/Hemichordata split (Fig. 1A). As a
result, it might be misleading to classify the Branchiostoma sp. and
Saccoglossus sp. sequences as ‘‘a2’’ (as they are) or even ‘‘a1’’, as they
are neither. The dearth of fish sequences for the a subunit makes it
difficult to interpret the phylogenetic dynamics of this subunit
here. On the other hand, the b subunit clearly shows evidence for
the fish-specific WGD event, here dated between ,0.560 and
0.180 BYA, as all the gene duplicates seem to have been preserved
(Ediacaran to Lower Carboniferous; Fig. 1B). Note that the b1.1
sequence obtained in this study (our nomenclature) is of poor
quality, which explains its odd placement on the tree (with a very
high probability); yet, this does not affect the results of this
phylogenetic analysis thanks to the wide sequence sampling
adopted here. These two fish-specific b subunits highlight the
difficulty noted in the case of a (and of c below) regarding the
interpretation of the dynamics of these genes in fish where
subsequent genome duplication events and differential gene loss
can affect the shape of the ‘‘fish gene’’ clades. For instance,
tentative evidence for the salmonid-specific WGD-4 can be seen in
the fish a1 (between HQ403672 and BT072499), c1.2 (between
HQ403676 and NM_001141762) and c2.2 (between HQ403678
and BT072499) divergences that occurred around 0.100 to 0.025
BYA, which is consistent with previous estimates [28]. Finally, the
history of the c subunit appears to have much deeper roots than
that of the two other subunits (Fig. 1C). The (c1,c2)/c3 split is
very ancient, probably dating back to the first vertebrate WGD
event (around 1 BYA). The c1/c2 divergence occurred at the
same time the paralogs of the a and b subunits emerged, during
the second WGD event. In spite of being highly supported, the
phylogeny of the fish-specific genes does not reflect the species
tree. In particular, the phylogenetic reconstruction seems to be
positively misleading for the fish-specific c2 paralogs, whose
identification in Figure 1C should therefore be taken as an
approximation. The general phylogenetic pattern can however be
explained by differential gene loss after the fish-specific WGD
event. Nonetheless, a1/a2, b1/b2 and c1/c2 all diverged at the
same time, at the occasion of the vertebrate second WGD event.
AMPK phosphorylation status
The phosphorylation status of AMPK (threonine-172) and the
total AMPK levels in liver of fasted rainbow trout after ip injection
of AICAR or metformin is reported on Figure 2. Although in
both experiments the AMPK Thr
172 phosphorylation status was
higher after treatment, the effect exerted by metformin (3-fold
increase) was lower than that of AICAR (up to 10-fold increase).
No changes were found in the total level of AMPK.
The phosphorylation status of ACC (serine-79) in liver of fasted
rainbow trout after ip-injected AICAR or metformin is reported
on Figure 3. AICAR injection had no effect on the phosphor-
ylation status of ACC Ser
79, although we did observe significant
variability between fish for this analysis. In contrast, metformin
injection resulted in a significant two-fold up-regulation of the
ACC phosphorylation status compared to the saline control group.
Hepatic glycogen levels in trout ip-injected with either AICAR
or metformin are shown in Figure 4. When compared with the
saline control group, fish receiving AICAR showed significantly
higher glycogen levels. In contrast, a significant decrease (up to 4-
fold) in glycogen levels occurred in fish receiving the metformin
injection.
Analysis of the phosphorylation status of AMPK and ACC as
well as total AMPK and b-tubulin levels in cultured hepatocytes of
rainbow trout is shown in Figure 5. AMPK phosphorylation was
only detected in hepatocytes stimulated with AICAR, while no
detectable signal was found in either saline control or metformin-
treated cells. However, total AMPK protein was found in all
treatments, although the bands observed in the group stimulated
with AICAR were shifted, possibly as a result of changes in the
molecule when phosphorylated. Similar to the results found for the
phosphorylated AMPK, the phosphorylation status of ACC
(detected in all cells) increased only when AICAR was added to
the culture medium. No changes were found in the housekeeping
protein b-tubulin among treatments.
The phosphorylation status of AMPK at Thr
172 and total
AMPK levels in trout fasted for 10 days and re-fed is shown in
Figure 6. The levels of the phosphorylated AMPK were strongly
down-regulated in re-fed fish sampled 1 h after the meal (,50-
fold), while at 24 h the phosphorylation status of the kinase in the
re-fed fish were intermediate between the fasted and re-fed 1 h
groups.
The phosphorylation status of AMPK at Thr
172 and the total
AMPK protein levels, mRNA levels of AMPK a1 and a2 as well
as glycogen levels in the liver of rainbow trout fed with a high
carbohydrate diet with or without metformin are shown in
Figure 7. While no significant differences were noted for glycogen
levels, AMPK phosphorylation status was significantly depressed
by metformin feeding (mostly due to the increased in the total
AMPK content) while mRNA levels of AMPKa1 were signifi-
cantly up-regulated in these same fish.
Enzyme transcript abundance
mRNA transcript levels for proteins involved in glucose and
lipid metabolism after AICAR or metformin treatments (in vivo and
in vitro) are shown in Table 2. GK mRNA expression level was
significantly down-regulated both in vivo and in vitro in the presence
of AICAR, which probably was also responsible for AMPK
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GK mRNA expression level changed only in the in vivo
experiments, possibly as a result of the differences between the
hepatocytes that were cultured in media containing insulin and
glucose, while the fish used in the in vivo trial were fasted for 48 h.
Similar to the changes found for GK, G6Pase mRNA transcript
abundance was also reduced when compared with the control in
both AICAR trials. In contrast, no changes were observed with the
metformin treatment, either in vivo or in vitro. Two enzymes
involved in gluconeogenesis, FBPase and PEPCK, demonstrated
no changes for any treatment or for either in vivo or in vitro
experiments. A contrary effect of the AICAR treatment was found
comparing the data obtained in vivo and in vitro regarding the FAS
mRNA levels. Thus, FAS mRNA expression levels were
significantly up-regulated in vivo, but down-regulated in vitro.N o
significant differences in FAS mRNA abundance were found with
the metformin treatment, although a general trend to down-
regulate was observed.
Discussion
Phylogenetic analysis
Our phylogenetic analysis clearly shows the near-simultaneous
emergence of the AMPK subunit paralogs at the occasion of the
second vertebrate-specific WGD event. The fish-specific WGD
event led to the emergence of additional paralogs, retained for the
b1, c1 and c2 subunits. We could not find evidence for any other
fish-specific paralogs, be it in GenBank or through our sequencing
effort in rainbow trout, which does not mean however that these
sequences have been lost. Note that no fish-specific paralogs were
found in the a subunit, which might be linked to the presence of
the activation site at Thr
172 and to the conserved function of
AMPK across vertebrates (see below for experimental evidence).
Although we present here the first attempt at a phylogenetic
analysis of this important nutrient sensor, deeper sequencing
efforts are required to unravel the complex history of AMPK
subunits in fish models such as the rainbow trout, and its
relationship with the emergence of AMPK functions.
AICAR and metformin-induced AMPK phosphorylation in
trout liver and hepatocytes
Our study demonstrates for the first time in rainbow trout the
presence of AMPK in its total form and, more importantly, the
phosphorylation at the Thr
172 of the a subunit. The binding of
AMP to the c subunit activates AMPK via a complex mechanism
involving direct allosteric activation and phosphorylation of the a
subunit on the Thr
172 by upstream kinases such as the protein
kinase LKB1 and the CaMKKIIb [1]. Our first objective was to
activate AMPK in trout liver to evaluate the metabolic events
triggered by activation of this kinase. To do so, we developed two
in vivo experiments, injecting fasted trout with two mammalian
activators of AMPK, AICAR [29] and metformin [11]. Both
AICAR and metformin were able to induce AMPK phosphory-
lation in trout liver at 2 h post-drug administration. This is the first
evidence that phosphorylation of AMPK can be pharmacologi-
cally-induced in a fish. Two bands of the expected molecular
weight (,65-70 kDa) were detected, consistent with the two
AMPK a-isoforms present in rainbow trout in which a threonine
at position 172 (Thr
172) was found (see GenBank accession
HQ403672 and 403673). The fact that these same drugs are able
Figure 2. Effect of intraperitoneal (ip) administration of saline solution alone or containing AICAR (1.2 g?kg
21) or metformin
(120 mg?kg
21) on rainbow trout liver AMPK phosphorylation status (at threonine 172; Western blot analysis). Fish were fasted (48 h)
prior to injection and livers were sampled 2 h after injection. Gels were loaded with 20 mg total protein per lane. Protein (total AMPK) and
phosphorylation levels (AMPK Thr
172) were normalized to tissue b-tubulin levels. Results are expressed as means 6 s.e.m. (n=6) and were analyzed by
one-way ANOVA followed by Student-Newman-Keuls comparison test. *Significant difference (a,0.05).
doi:10.1371/journal.pone.0020228.g002
Figure 1. Joint-dated phylogeny of the AMPK subunits. (A) subunit a; (B) subunit b; (C) subunit c. Sequences obtained in this study are in bold
and green; mis-annotated database sequences (NCBI) are in gray. Posterior probabilities are indicated only when ,0.70 (all the others are $0.70).
Error bars (95% Highest Posterior Densities or HPDs) are given only for two genome-wide duplication (GWD) events when these are still visible by the
pattern of paralogs: the second round (GWD-2) in vertebrates and the fish-specific event (GWD-3). Mean posterior estimates are indicated by ‘‘+’’
signs. The 95% HPDs of these GWD events are shaded in red and blue, respectively and were constructed from the union of HPDs taken over all
detected paralogs across all three subunits. TSA: Transcriptome Shotgun Assembly.
doi:10.1371/journal.pone.0020228.g001
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mammals [29] supports the conserved nature of AMPK function,
at least in the vertebrates. The activation of AMPK by metformin
traditionally used as an anti-diabetic drug in the trout model
constitutes a novel finding [32]. Musi et al. [33] did demonstrate
that metformin stimulated AMPK activities in skeletal muscle of
rats with type 2 diabetes. The activation of AMPK by metformin
has been elusive in fish, as after the administration of this
drug in rainbow trout (infused ip at relatively low doses,
20 mg?kg
21?day
21) the phosphorylation of this kinase was not
detected [13]. Unfortunately, in other studies in which metformin
was administrated to fish, including zebrafish (transdermally [34])
or common carp (ip [12]), AMPK activation was not explored.
Additionally, we present in this study the phosphorylation status of
AMPK in fish fed a high carbohydrate diet supplemented with
metformin. After 3 days of feeding, no activation of AMPK was
found even though mRNA expression levels of the a1 subunit (the
major a isoform in liver) and the total AMPK expression levels
(data not shown) were up-regulated. The fact that in similar
feeding studies with trout (e.g., [14]), metformin did result in
normoglycemia in high-carbohydrate fed fish and the lack of
AMPK activation in the present study, reinforces the idea that the
normoglycemic effect of metformin in trout is AMPK-indepen-
dent. The fact that the phosphorylation of AMPK was higher after
AICAR administration than with metformin may relate to the
dose employed being 10-fold higher for AICAR. However, the
mechanism through which each drug activates AMPK is in fact
different. AICAR is known to be phosphorylated to 5-amino-4-
imidazolecarboxamide ribotide (ZMP), which is an analogue of
AMP and mimics several of the cellular effects of adenine,
including replacing 59-AMP as an AMPK activator [35].
Metformin, however, stimulates LKB1 kinase, which in turn,
phosphorylates AMPK [11]. LKB1 phosphorylation status at
Ser
428 was evaluated in the present study, but no bands for LKB1
Figure 4. Effect of intraperitoneal (ip) administration of saline solution alone or containing AICAR (1.2 g?kg
21) or metformin
(120 mg?kg
21) on rainbow trout liver glycogen levels. Fish were fasted (48 h) prior to injection and livers were sampled 2 h after injection.
Results are expressed as means 6 s.e.m. (n=6) and were analyzed by one-way ANOVA followed by Student-Newman-Keuls comparison test.
*Significant difference (a,0.05).
doi:10.1371/journal.pone.0020228.g004
Figure 3. Effect of intraperitoneal (ip) administration of saline solution alone or containing AICAR (1.2 g?kg
21) or metformin
(120 mg?kg
21) on rainbow trout liver ACC phosphorylation status (at serine 79; Western blot analysis). Fish were fasted (48 h) prior to
injection and livers were sampled 2 h after injection. Gels were loaded with 20 mg total protein per lane. Protein and phosphorylation levels were
normalized to tissue b-tubulin levels. Results are expressed as means 6 s.e.m. (n=6) and were analyzed by one-way ANOVA followed by Student-
Newman-Keuls comparison test. *Significant difference (a,0.05).
doi:10.1371/journal.pone.0020228.g003
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shown).
Further support for the induction of AMPK phosphorylation in
trout liver was found using hepatocytes primary cultures
stimulated with either AICAR or metformin. Consistent with the
in vivo study, AICAR after a 16 h incubation induced AMPK
phosphorylation. However, no AMPK phosphorylation was found
in the metformin-stimulated hepatocytes in clear contrast with the
ip in vivo results. Since the antibody used in the present study is not
specific for trout, it is possible that AMPK phosphorylation was
below the detection level of the particular antibody used.
However, we can also hypothesize that the dose used for the
stimulation was too low since studies with mammalian hepatocytes
show maximum AMPK phosphorylation was achieved at 2 mM
metformin [26], or 4 times-higher than used in the present study.
Finally, we assessed the phosphorylation status of liver AMPK
in trout subjected to a fasting-re-feeding trial. After 10 days of
food-deprivation trout were re-fed and 1 h later, the AMPK
phosphorylation status was significantly decreased, while 24 h
after this first meal the levels trend to recover to those of the fasted
fish. Although we are unaware whether a 10-day fast is adequate
to cause energy stress in this species which is able to fast for weeks
[36], the down-regulation of AMPK phosphorylation after the first
meal matches the expected inhibition of this kinase under energy
surplus conditions demonstrated in mammals [1]. The fact that
AMPK can be dynamically (de-)phosphorylated in trout liver
under physiological conditions supports the idea that this kinase
exerts a relevant role on fish metabolism in accordance with its
previously reported function in hypoxic cyprinids [4,5,6]. Whether
AMPK is working as an energy sensor key to rainbow trout liver
function or not requires further studies.
Indirect evidence of AMPK activity in trout liver and
hepatocytes
One of the main downstream targets of mammalian AMPK is
the lipogenic enzyme ACC. ACC-serine79 is directly phosphor-
ylated by this kinase to inhibit its activity [37]. Consequently the
phosphorylation status of ACC is also considered as an indirect
indicator of AMPK activity [38]. Only metformin in our in vivo
trials induced a significant increase in phospho-ACC protein levels
while a slight increase was noted in phospho-ACC in trout
hepatocytes, suggesting some degree of AMPK activation, possibly
not detected in our present conditions as discussed above. The in
vivo effect of metformin is not only consistent with the increased
phosphorylation status of the AMPK, but also with the ability of
this drug to repress lipogenesis in the liver of mammalian species
Figure 7. AMPK phosphorylation status (at threonine 172;
Western blot analysis), mRNA levels of AMPKa1 and AMPKa2
and glycogen levels in livers of rainbow trout fed with 30%
carbohydrates or 30% carbohydrates + metformin (0.25%) for
3 days. Gels were loaded with 20 mg total protein per lane. Protein
(total AMPK) and phosphorylation levels (AMPK Thr
172) were normalized
to tissue b-tubulin levels. mRNA levels were estimated using real-time
RT-PCR. Expression levels were normalized to b-actin-expressed
transcripts which did not change under the experimental conditions
and are presented as fold-change against the saline solution-treated
group set to 1. Results are expressed as means 6 s.e.m. (n=6) and were
analyzed by one-way ANOVA followed by Student-Newman-Keuls
comparison test. *Significant difference (a,0.05).
doi:10.1371/journal.pone.0020228.g007
Figure 6. AMPK phosphorylation status and total AMPK
protein levels in rainbow trout fasted for 10 days and re-fed
once and assessed 1 and 24 h after the meal. Gels were loaded
with 20 mg total protein per lane.
doi:10.1371/journal.pone.0020228.g006
Figure 5. AMPK and ACC phosphorylation status, AMPK, ACC,
b-tubulin total protein levels on rainbow trout hepatocyte cell
culture 16 h after stimulation with AICAR (0.5 mM) or metfor-
min (0.5 mM). Gels were loaded with 20 mg total protein per lane.
Western blots were performed on three individual samples and similar
results were obtained.
doi:10.1371/journal.pone.0020228.g005
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term treatment of trout with metformin did not stimulate AMPK
phosphorylation in the liver, but it did up-regulate the lipogenic
potential, including FAS gene expression and activity [13,14].
These data confirm the ability of AMPK to exert a similar control
on lipogenesis in fish as in mammals [39], but also that the
increased lipogenesis observed after chronic metformin treatments
in trout is probably AMPK-independent [13,14]. Surprisingly, no
in vivo induction of ACC phosphorylation was found in the present
study, although as noted the AICAR trial showed considerable
variability. However, the results obtained in AICAR-stimulated
hepatocytes strongly support an increased ACC phosphorylation
that resulted from an AICAR-dependent AMPK activation. As
stated above, the ACC phosphorylation is consistent with a
decreased ACC activity and also with the down-regulated mRNA
levels of FAS observed in our previous in vivo studies [40] and as
described in mammals [41]. The fact that FAS gene expression is
increased in vivo after AICAR injection is surprising and could be
also related with the pharmacological AICAR dose used in the
present study. Other metabolic markers addressed here have not
previously been explored in fish before with AMPK activation,
and constitute important data concerning potential metabolic
AMPK functions in fish.
Metabolic events related with the AMPK phosphorylation
in rainbow trout
AICAR effects on metabolic-related genes in liver and
hepatocytes of trout other than FAS discussed above can be
summarized as the down-regulation of GK and G6Pase mRNA
expression levels, while the gluconeogenic genes assessed (PEPCK
and FBPase) were unaffected. The results obtained both in vivo
and in vitro are internally consistent, re-enforcing the idea that the
AICAR-induced AMPK activation is the main mediator of such a
regulation. Moreover, our results are in agreement with the main
function of AMPK in mammals where it acts as a master
regulator of energy production, repressing anabolic and stimu-
lating catabolic processes [1]. Thus, the down-regulation of
G6Pase observed here is consistent with the AICAR induced-
inhibition of gene expression of this enzyme described in
mammals [42]. Similarly, the repression of GK, considered as
one of the key regulators of both glycogenesis and lipogenesis in
liver [43], is consistent with the above-mentioned roles of AMPK
in mammals.
Although these data are consistent with the results obtained for
glycogen levels in AICAR-injected trout, they are in clear
disagreement with those reported in mammals where AMPK a
activation leads to the inhibition of glycogen synthase [44].
However, in mice [45], as in the present study (data not shown),
acute AICAR administration promoted significant hypoglycemia,
probably triggering the counter-regulatory response that resulted
in the depletion of the hepatic glycogen stores [46]. Concerning
glycogen levels in metformin-treated trout, the regulation appears
more complex. When administrated ip in trout, we found that
metformin decreased glycogen levels, as reported in mammals [47]
and consistently with AMPK activation [44]. However, no
hypoglycemic effects of the drug were found in our study, in
contrast with reduction in plasma glucose levels reported 1 h after
ip-metformin administration in rats [48]. On the other hand,
chronic metformin treatment either did not alter AMPK
activation [40] or reduced it (present study), even though
hypoglycemia is systematically observed. Consistently with these
results, we suggest that the hypoglycemic effect of metformin in
trout is not linked to AMPK activation, while some of the effects
directly linked to the metformin-dependent AMPK activation (i.e.
changes in glycogen) were not observed when hypoglycemia
appeared and AMPK was not activated.
Conclusions and Perspectives
We clearly demonstrate in this paper the presence of AMPK in
rainbow trout. In particular we present evidence regarding the
retention of paralogs that emerged during the fish-specific whole-
genome duplication event for the b and c subunits, while the a
subunit does not seem to show any evidence of such a duplication
event, presumably because of the loss of the corresponding
paralog. This loss might be in relation to the functional role of the
a subunit, a possibility that should be investigated by extended
sequencing studies. We also show for the first time evidence for
AMPK activation through the phosphorylation of the AMPK a at
Thr
172, and changes in phosphorylation pattern under physiolog-
ical and pharmacological conditions. Moreover, the phosphoryla-
tion of this kinase by two recognized AMPK activators (AICAR
and metformin) does induce changes in the main downstream
target, the phosphorylation of ACC, as well as changes in glycogen
levels and in several molecular actors involved in hepatic glucose
and lipid metabolism. Further confirmation of our results can be
found in the effects exerted mainly by AICAR in trout hepatocytes
Table 2. In vivo (2 h after ip administration) and in vitro (16 h of incubation) effects of AICAR (1.2 g?kg
21 or 0.5 mM in the
medium) or metformin (120 mg?kg
21 or 0.5 mM) in rainbow trout on mRNA transcript levels of hepatic genes representative of
glucose and lipid metabolism.
In vivo In vitro
Control AICAR Metformin Control AICAR Metformin
GK 1.0560.2 0.3260.06* 18.4862.03* 1.0660.2 0.3260.05* 0.8960.12
G6Pase 1.1260.11 0.5160.05* 1.0260.09 1.5260.71 0.8960.38* 1.3860.49
FBPase 1.1060.18 1.5060.19 1.4360.21 1.0360.16 0.9060.12 1.0860.13
PEPCK 1.1660.19 1.1760.23 0.5360.11 1.0360.15 1.0260.18 1.0060.20
FAS 1.0960.16 2.5160.21* 0.6760.17 1.0560.19 0.2960.05* 09660.16
GK (glucokinase), G6Pase (glucose 6-phosphatase), FBPase (fructose 1,6-bisphosphatase), PEPCK (phosphoenolpyruvate carboxykinase), FAS (fatty acid synthase) Results
are expressed as means 6 s.e.m. (n=6) and were analyzed by one-way ANOVA followed by Student–Newman–Keuls comparison test.
*Significant difference (P,0.05). mRNA levels were estimated using real-time RT-PCR and normalized to elongation factor 1a (EF1a) transcripts which did not change
under the experimental conditions.
Data are presented as relative ratios of the target gene to the reference gene (EF1a).
doi:10.1371/journal.pone.0020228.t002
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fact that many of our in vivo and in vitro results are consistent with
the recognized role of AMPK as a master regulator of energy
homeostasis in organisms [1,2] supports the idea that these
functions are conserved also in the piscine model. Further studies,
however, must be conducted in order to clarify the AMPK-related
functions on fish metabolism. As a link between glucagon and
lipids in the regulation of hepatic AMPK signaling was recently
found [49], further studies are needed to link hormone levels with
this key signaling process.
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